Avexegen Therapeutics
company
About
Avexegen Therapeutics is an early stage development company working on novel and revolutionary therapies for the $10 Billion GI Market.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $2.94M
- Industries
- Biotechnology,Therapeutics
- Founded date
- Jan 1, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$2.94M
Avexegen Therapeutics has raised a total of
$2.94M
in funding over 2 rounds. Their latest funding was raised on
Feb 15, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 15, 2021 | Grant | $2.94M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Avexegen Therapeutics is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
